NUTRA PHARMA CORP Quarterly Debt-to-equity in % from Q3 2014 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Nutra Pharma Corp quarterly Debt-to-equity history and growth rate from Q3 2014 to Q3 2022.
  • Nutra Pharma Corp Debt-to-equity for the quarter ending September 30, 2022 was -104 %, a 2.48% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 -104 -2.53 -2.48% Sep 30, 2022
Q2 2022 -104 -2.52 -2.48% Jun 30, 2022
Q1 2022 -103 -1.23 -1.21% Mar 31, 2022
Q4 2021 -102 +1.15 +1.11% Dec 31, 2021
Q3 2021 -102 +1.46 +1.41% Sep 30, 2021
Q2 2021 -102 Jun 30, 2021
Q1 2021 -102 Mar 31, 2021
Q4 2020 -103 Dec 31, 2020
Q3 2020 -103 Sep 30, 2020
Q2 2019 -105 +2.7 +2.51% Jun 30, 2019
Q1 2019 -106 -0.55 -0.52% Mar 31, 2019
Q4 2018 -107 -2.61 -2.51% Dec 31, 2018
Q3 2018 -108 -4.64 -4.48% Sep 30, 2018
Q2 2018 -108 -2.94 -2.81% Jun 30, 2018
Q1 2018 -106 +0.37 +0.35% Mar 31, 2018
Q4 2017 -104 +2.6 +2.44% Dec 31, 2017
Q3 2017 -104 +4.77 +4.41% Sep 30, 2017
Q2 2017 -105 +4.5 +4.12% Jun 30, 2017
Q1 2017 -106 +5.08 +4.58% Mar 31, 2017
Q4 2016 -107 +5.98 +5.3% Dec 31, 2016
Q3 2016 -108 +4.48 +3.97% Sep 30, 2016
Q2 2016 -109 +3.14 +2.79% Jun 30, 2016
Q1 2016 -111 -0.69 -0.63% Mar 31, 2016
Q4 2015 -113 -5.7 -5.32% Dec 31, 2015
Q3 2015 -113 -7.6 -7.23% Sep 30, 2015
Q2 2015 -112 Jun 30, 2015
Q1 2015 -110 Mar 31, 2015
Q4 2014 -107 Dec 31, 2014
Q3 2014 -105 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.